Article
Organic Anion Transporter Polypeptide 1B1 Polymorphism Modulates the Extent of Drug-Drug Interaction and Associated Biomarker Levels in Healthy Volunteers.
Clinical and translational science - 1 Jul 2019
Yee Sook Wah, Giacomini Marilyn M, Shen Hong, Humphreys W Griffith, Horng Howard, Brian William, Lai Yurong, Kroetz Deanna L, Giacomini Kathleen M
Abstract excerpt
Understanding transporter-mediated drug-drug interactions is an integral part of risk assessment in drug development. Recent studies support the use of hexadecanedioate (HDA), tetradecanedioate (TDA), coproporphyrin (CP)-I, and CP-III as clinical biomarkers for evaluating organic anion-transporting polypeptide (OATP)1B1 (SLCO1B1) inhibition. The current study investigated the effect of OATP1B1 genotype c.521T>C...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
